S100A3 and ovarian carcinoma: FAM198B may act to favor tumor progression by interacting with numerous genes, such as the p-ERK/MMP-1 signaling pathway in lung adenocarcinoma [9], and S100A3, PCDH9, and SEMA3A genes in ovarian cancer [8,34].